Key TakeawaysNovo Nordisk A/S ([NOVO B](/stock/NOVO B)) has proposed Lars Rebien Sørensen as the new interim Chair of its board of directors, effective until the next Annual General Meeting (AGM).The nomination follows a significant board overhaul, with current Chair Helge Lund and six other board members stepping down due to recent market challenges and a decline in the company's share price since mid-2024.The Novo Nordisk Foundation, the majority voting shareholder of Novo Nordisk through Novo Holdings A/ ...